ARCHIVES

Early ADT Doesn’t Offer Survival Advantage—ASCO

This article is from The Cancer Letter archive.

Vol. 30 No. 4 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

Judge Declines To Issue Injunction To Stop Amgen’s “Bundling.”

December 1, 2006

Full Funding Of Indirect Costs, Other Mandates By Congress Chew Up Most Of NCI’s Extra Money

December 2, 1983

Advisors Approve Program To Link Radiation Oncologists.

June 29, 2001

More Women Over 50 Report Having Had Mammograms.

July 28, 2000

Avastin For Adjuvant Treatment Of Colon Cancer Showed Benefit At One Year, But Failed Overall

June 5, 2009